Table 3.

Cumulative incidence of IHa

ParameterPediatric PatientsAdult Patients
n12 Mo (%)36 Mo (%)n12 Mo (%)36 Mo (%)
Any IH
    all dialysis248122.143.2333,45331.452.5
    HD146921.339.9305,32331.852.6
    PD98223.451.227,11924.451.8
    unknown308.0No estimateb101118.529.9
    KTx110833.347.431,66325.539.8
    all patients358925.743.9365,11630.851.0
    P, HD versus KTx<0.0001<0.0001<0.0001<0.0001
    P, PD versus KTx<0.00010.0074<0.0001<0.0001
UTI
    all dialysis24811.84.1333,4532.24.8
    HD14691.94.7305,3232.34.9
    PD9821.72.727,1191.23.0
    unknown300.00.010110.60.6
    KTx110811.116.831,6635.510.0
    all patients35895.19.1365,1162.55.4
    P, HD versus KTx<0.0001<0.0001<0.0001<0.0001
    P, PD versus KTx<0.0001<0.0001<0.0001<0.0001
Access device
    HD or PD24519.622.0332,44210.619.3
    HD146911.623.2305,32311.019.5
    PD9826.321.327,1194.416.9
    P, HD versus PD<0.00010.0026<0.0001<0.0001
  • a HD, hemodialysis; IH, infection-related hospitalizations, KTx, kidney transplant; PD, peritoneal dialysis; UTI, urinary tract infection.

  • b Follow-up time for all 30 patients in this group was censored before the end of 3 yr, making the cumulative incidence at 3 yr nonestimable from Kaplan-Meier methods.